Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Enveric Biosciences (ENVB) has appointed Carter Ward as CFO, effective May 15th, 2021. He is replacing John Van Buiten. Prior to joining the company, Ward most recently served as CFO at Elite Pharmaceuticals. John Van Buiten is expected to remain in a consulting role with the company.


RTTNews | Apr 12, 2021 07:43AM EDT

07:43 Monday, April 12, 2021 (RTTNews.com) - Enveric Biosciences (ENVB) has appointed Carter Ward as CFO, effective May 15th, 2021. He is replacing John Van Buiten. Prior to joining the company, Ward most recently served as CFO at Elite Pharmaceuticals. John Van Buiten is expected to remain in a consulting role with the company.

"Since becoming a public company in late-December 2020, Enveric has already achieved notable strategic milestones, working diligently to execute its vision of bringing new-generation, naturally occurring and synthetic compounds to cancer patients who need better, safer supportive care treatments," said Ward.

Read the original article on RTTNews ( https://www.rttnews.com/3184134/enveric-biosciences-names-carter-ward-cfo-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC